Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 7Myeloid 7Plasma cell 6Lymphoid 6Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 9Leukemia, Myelomonocytic, Chronic 8Anemia, Refractory, with Excess of Blasts 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 5Lymphoma, Non-Hodgkin 5Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Anemia, Refractory 4Primary Myelofibrosis 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Chronic-Phase 3Leukemia 3Thrombocythemia, Essential 2Polycythemia Vera 2Multiple Myeloma 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Prolymphocytic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Waldenstrom Macroglobulinemia 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Prolymphocytic, T-Cell 1

Interventions

Cyclophosphamide 22fludarabine phosphate 18Busulfan 16Antilymphocyte Serum 15Radiotherapy 12Cyclosporine 11Cord Blood Stem Cell Transplantation 11Peripheral Blood Stem Cell Transplantation 10Melphalan 10Filgrastim 10Tacrolimus 9Mycophenolic Acid 9Methylprednisolone 9Methotrexate 9Etoposide 7Cytarabine 7Whole-Body Irradiation 6sargramostim 4Tretinoin 3Thalidomide 3Carboplatin 3venetoclax 2ruxolitinib 2Thiotepa 2Thioguanine 2Specimen Handling 2Sirolimus 2Rituximab 2Leucovorin 2Immunoenzyme Techniques 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic-Myeloproliferative Diseases × Cyclosporins × Classical hematology × Clear all
NCT00045305 2023-06-28

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Eastern Cooperative Oncology Group

Phase 2 Completed
17 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡